Robert Hershberg, Director at Adaptive Biotechnologies Corp (ADPT), sold 3,378 shares at $66.34 ($225K) on 2021-01-15, disclosed to the SEC on 2021-01-20.
Open-market sale of $225k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.34 | 1,378 | $91K | 40.7% |
| 2 | $66.34 | 1,378 | $91K | 40.7% |
| 3 | $67.05 | 622 | $42K | 18.6% |
| Total | $66.47 avg | 3,378 | $225K | 100% |
| Filing → |
| ADPT | SELL | 2025-12-12 | $367K | — | Filing → |
| ADPT | SELL | 2025-03-12 | $402K | — | Filing → |
| HLVX | SELL | 2025-02-12 | $49K | — | Filing → |